GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

HyperDynamics Corporation (HDY) CFO Paul C Reinbolt buys 100,000 Shares

February 15, 2013 | About:
10qk

insider

57 followers
CFO and Executive VP of HyperDynamics Corporation (HDY) Paul C Reinbolt buys 100,000 shares of HDY on 02/15/2013 at an average price of $0.62 a share.

Hyperdynamics Corporation has a market cap of $104 million; its shares were traded at around $0.6 . Hyperdynamics Corporation had an annual average earning growth of 15.8% over the past 10 years.

CFO Recent Trades:



  • CFO and Executive VP Paul C Reinbolt bought 100,000 shares of HDY stock on 02/15/2013 at the average price of 0.62. Paul C Reinbolt owns at least 130,000 shares after this.

This is the insider trade history vs. stock price of HDY. For the complete insider trading history of HDY, click here.




Directors and Officers Recent Trades:



  • Director David Owen bought 29,750 shares of HDY stock on 01/17/2013 at the average price of 0.58. David Owen owns at least 425,150 shares after this.
  • Director Herman Jay Cohen bought 10,000 shares of HDY stock on 09/24/2012 at the average price of 0.72. Herman Jay Cohen owns at least 61,000 shares after this.
  • Director Herman Jay Cohen bought 10,000 shares of HDY stock on 09/18/2012 at the average price of 0.79. Herman Jay Cohen owns at least 51,000 shares after this.
  • Senior VP for Operations Michael W. Palmer sold 30,000 shares of HDY stock on 01/18/2013 at the average price of 0.58. Michael W. Palmer owns at least 99,467 shares after this.


For the complete insider trading history of HDY, click here.

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 1.0/5 (1 vote)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK